Filing Flows › NRX Pharmaceuticals (NRXP) › Procedures revenue
NRX Pharmaceuticals (NRXP) Procedures revenue by quarter
NRX Pharmaceuticals' Procedures revenue was $230K in Q2 2026 (second quarter 2026), -25% from Q1 2026. Over the last 4 quarters it ranged from $90K (Q3 2025) to $308K (Q1 2026).
| Quarter | Procedures revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $230K | -25% | — |
| Q1 2026 | $308K | +10% | — |
| Q4 2025 | $281K | +212% | — |
| Q3 2025 | $90K | — | — |
Q2 2026 at a glance
NRX Pharmaceuticals, Q2 2026: revenue $1.1M, operating margin -590.8%, net loss $16.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is NRX Pharmaceuticals' Procedures revenue?
NRX Pharmaceuticals' Procedures revenue was $230K in Q2 2026 (second quarter 2026), -25% from Q1 2026.
How has NRX Pharmaceuticals' Procedures revenue changed?
Over the last 4 quarters it ranged from $90K (Q3 2025) to $308K (Q1 2026).